Nabatov, A. A., Pollakis, G., Linnemann, T., Kliphius, A., Chalaby, M. I. M., & Paxton, W. A. (2004). Intrapatient Alterations in the Human Immunodeficiency Virus Type 1 gp120 V1V2 and V3 Regions Differentially Modulate Coreceptor Usage, Virus Inhibition by CC/CXC Chemokines, Soluble CD4, and the b12 and 2G12 Monoclonal Antibodies. American Society for Microbiology.

Nabatov, Alexey A., Georgios Pollakis, Thomas Linnemann, Aletta Kliphius, Moustapha I. M. Chalaby, och William A. Paxton. Intrapatient Alterations in the Human Immunodeficiency Virus Type 1 Gp120 V1V2 and V3 Regions Differentially Modulate Coreceptor Usage, Virus Inhibition By CC/CXC Chemokines, Soluble CD4, and the B12 and 2G12 Monoclonal Antibodies. American Society for Microbiology, 2004.

Nabatov, Alexey A., et al. Intrapatient Alterations in the Human Immunodeficiency Virus Type 1 Gp120 V1V2 and V3 Regions Differentially Modulate Coreceptor Usage, Virus Inhibition By CC/CXC Chemokines, Soluble CD4, and the B12 and 2G12 Monoclonal Antibodies. American Society for Microbiology, 2004.